"PCPs Take Charge in Gene Therapy Era as RSV Shot Gets Green Light for Infants"

Primary care physicians are playing a crucial role in the new era of gene therapy, as they are often the first to diagnose and deliver news of genetic diseases to patients. With the approval of numerous gene therapies for rare and debilitating diseases, primary care doctors will be responsible for monitoring patients' safety, managing side effects, and coordinating care with subspecialists. However, the lack of time and support for doctors in this field remains a challenge. As gene therapy becomes more prevalent, primary care physicians will need to be equipped with the knowledge and resources to interpret genetic test results and provide counseling to patients. The expansion of gene therapy also raises concerns about the overwhelming learning curve for primary care doctors and the need for additional support, such as artificial intelligence tools, to assist in patient care.